Skip to main content
. 2015 Oct 5;2015:862485. doi: 10.1155/2015/862485

Figure 2.

Figure 2

The ASCs and ELCs were transplanted into the neonatal rats to investigate the protection of cell-based therapy in hypoxic-ischemic (HI) brain injury. Significant preservation of brain damage was observed in ELCs treatment as compared to the PBS injection (a). Both ASCs and ELCs therapies showed prevention of brain loss in Nissl staining after HI injury (b). N = 6, p < 0.05 compared to PBS-treated rats.